RecruitingPhase not listedNCT05489705
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Sponsor: Bristol-Myers Squibb
Grand Rapids, MI · West Bloomfield, MI · +58 more sites